Insiders who reported open-market trades in the last 12 months at the companies Douglas Carr files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Douglas Carr is a corporate insider, tracked as SVP Finance & Operations of Century Therapeutics, Inc. (IPSC). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Douglas Carr submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Douglas Carr been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($29K) across all tracked filings.
Douglas Carr is SVP Finance & Operations of Century Therapeutics, Inc. (IPSC). 14 SEC Form 4 filings on record going back to 2024, most recently on 15 September 2026. Most recent open-market trade: sold $3K of IPSC on 15 September 2026. Lifetime open-market sales: $29K.
Recent transactions
15
The latest 15 SEC Form 4 transactions reported by Douglas Carr.
InsiderAlpha's records for Douglas Carr go back to 2024: 14 primary Form 4 filings, an average of 4.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
